Friend,
The cost of life-saving prescription medicine in America is out of control. According to a poll by Kaiser Family Health, eight in ten adults say that the cost of prescription drugs is unreasonable. And almost 30 percent aren’t taking their medication as prescribed due to cost.
Thanks to the Inflation Reduction Act that Congress passed in 2022, vital medication is becoming more affordable. For the first time, Medicare has the power to negotiate prescription drug prices. Insulin costs have been capped at $35 per month for Medicare patients as a result.
Now, Eli Lilly has announced they’ll be capping out-of-pocket costs for insulin at $35 a month for everyone.
Make no mistake, Eli Lilly would not have taken these steps without pressure from the public and the federal government to make insulin more affordable. This is a huge step towards lowering the cost of a prescription drug that millions rely on to survive. But other pharmaceutical companies continue to inflate prices for profit.
Onward,
Ro
|
|
|
Email us: [email protected]
This email was sent to [email protected]. Email is the most important way we keep in touch with people like you, so thank you for reading to the end. Small donors like you keep us going. To contribute via check, please address to Ro for Congress, PO Box 3513, Santa Clara, CA 95051.
Paid for by Ro for Congress